go-v.orgdoi

The Putative Role of TP53 Alterations and p53 Expression in Borderline Ovarian Tumors - Correlation with Clinicopathological Features and Prognosis: A Mini-Review

Andrzej Semczuk, Marek Gogacz, Anna Semczuk‐Sikora, Maciej Jóźwik, Tomasz Rechberger · Journal of Cancer · 2017

  • DOI 10.7150/jca.19691
  • Publisher Ivyspring International Publisher
  • Type review
  • Issued 2017

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · review · 2017

Abstract

Borderline ovarian tumors (BOTs) represent an independent group among ovarian malignancies, being diagnosed at clinical stage earlier than invasive ovarian carcinomas (OCs) and characterized by a rather favorable outcome after careful surgical management.Data published worldwide showed a substantial discordance of p53 expression in BOTs.The purpose of this work was to present the current status of knowledge on the significance of TP53 gene and p53 protein product alterations in BOTs.In general, higher p53 expression patterns were reported for ovarian malignancies compared to BOTs.Serous, mucinous, and endometrioid BOTs differ substantially in relation to p53 immunostaining, but data concerning the relationship between the protein's immunoreactivity and other clinico-pathological variables are scarce.Finally, reports published to date support the view that TP53 alterations may not be commonly associated with the borderline phenotype of ovarian tumors but they probably occur during the development of invasive OCs.In light of these uncertainties, the impact of TP53 alterations and p53 expression on overall survival in women affected by BOTs requires further multi-institutional studies in large cohorts of patients.

Open the resolved locator · 10.7150/jca.19691

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 23:52 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v08p2684.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.